These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35552202)

  • 1. Addiction in the family: Two Indigenous families overcoming barriers to opioid agonist therapy.
    Lawford K; Newman A
    Can Fam Physician; 2022 May; 68(5):348-351. PubMed ID: 35552202
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.
    Fishman MJ; Wu LT; Woody GE
    Am J Psychiatry; 2011 Jul; 168(7):675-9. PubMed ID: 21724673
    [No Abstract]   [Full Text] [Related]  

  • 3. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.
    Wiegand TJ
    J Med Toxicol; 2016 Mar; 12(1):64-70. PubMed ID: 26574020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Barriers to Treatment of Opioid Use Disorder.
    Olsen Y; Fitzgerald RM; Wakeman SE
    JAMA; 2021 Mar; 325(12):1149-1150. PubMed ID: 33630021
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding Buprenorphine Use in Primary Care: Changing the Culture.
    Leiser A; Robles M
    Perm J; 2022 Jun; 26(2):177-180. PubMed ID: 35933665
    [No Abstract]   [Full Text] [Related]  

  • 7. Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?
    Weimer MB; Wakeman SE; Saitz R
    JAMA; 2021 Mar; 325(12):1147-1148. PubMed ID: 33630020
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.
    Lembke A; Ottestad E; Schmiesing C
    Pain Med; 2019 Mar; 20(3):425-428. PubMed ID: 29452378
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to Post-Acute Care for Patients on Opioid Agonist Therapy; An Example of Systematic Stigmatization of Addiction.
    Wakeman SE; Rich JD
    J Gen Intern Med; 2017 Jan; 32(1):17-19. PubMed ID: 27393486
    [No Abstract]   [Full Text] [Related]  

  • 11. Buprenorphine to treat opioid use disorder: A practical guide.
    Nissly T; Levy R
    J Fam Pract; 2018 Jun; 67(9):544-548. PubMed ID: 30216393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
    Gastberger S; Baumgartner MR; Soyka M; Quednow BB; Hulka LM; Herdener M; Seifritz E; Mutschler J
    Eur Addict Res; 2019; 25(4):207-212. PubMed ID: 31067528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Promises And Pitfalls Of Treating Addiction.
    Gregg JL
    Health Aff (Millwood); 2017 Dec; 36(12):2204-2206. PubMed ID: 29200333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A; Gonzalez G
    Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention.
    Williams AR; Mauro CM; Feng T; Wilson A; Cruz A; Olfson M; Crystal S; Samples H; Chiodo L
    Am J Psychiatry; 2023 Jun; 180(6):454-457. PubMed ID: 36285405
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment.
    Hickman M; Macleod J; Degenhardt L
    Addiction; 2016 Jan; 111(1):83-4. PubMed ID: 26669528
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of Drugs Used to Treat Opioid Use Disorder.
    Aschenbrenner DS
    Am J Nurs; 2018 Aug; 118(8):25. PubMed ID: 30048283
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone and buprenorphine treatments in patients with schizophrenia.
    Dervaux A; Plancke L; Amariei A; Trouiller P; Tahon M; Martinetti MP; Naassila M; Cottencin O; Danel T
    Schizophr Res; 2019 Jul; 209():286-288. PubMed ID: 31101511
    [No Abstract]   [Full Text] [Related]  

  • 20. Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
    Carney BL; Hadland SE; Bagley SM
    Pediatr Rev; 2018 Jan; 39(1):43-45. PubMed ID: 29292291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.